RxSight Inc (RXST)
58.47
-1.05
(-1.76%)
USD |
NASDAQ |
May 31, 16:00
58.35
-0.12
(-0.21%)
After-Hours: 20:00
RxSight Research and Development Expense (Annual): 29.05M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 29.05M |
| December 31, 2022 | 25.98M |
| December 31, 2021 | 24.50M |
| Date | Value |
|---|---|
| December 31, 2020 | 21.93M |
| December 31, 2019 | 29.57M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
21.93M
Minimum
2020
29.57M
Maximum
2019
26.21M
Average
25.98M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Alphatec Holdings Inc | 70.12M |
| Masimo Corp | 175.20M |
| Tactile Systems Technology Inc | 7.823M |
| iRhythm Technologies Inc | 60.24M |
| Shockwave Medical Inc | 145.65M |